Geoffrey C. Dunbar

Nessuna posizione attualmente

77 anni

Health Technology

Consumer Services

Precedenti posizioni note di Geoffrey C. Dunbar

Società	Posizione	Inizio	Fine
Targacept, Inc. Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC.	Direttore Tecnico/Scientifico/R&S	01/06/2001	31/05/2012
	Consigliere Generale	01/06/2001	31/05/2012

University of London

Doctorate Degree

Distribuzione geografica

Stati Uniti	2
Regno Unito	2

Posizioni

Settori

Health Technology	2
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Targacept, Inc. Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC.	Health Technology

Aziende private

Health Technology